Global COVAX initiative has 189 countries in its group till date, which is backed by the WHO and seeks to ensure equitable distribution of vaccines. The United States is not among them, having secured bilateral deals. The preliminary plan of COVAX programme is to vaccinate the 20% of populations at highest risk, including health workers and people aged over 65.
“The goal is to get at least 2 billion doses by end of 2021 which will be enough to vaccinate 20% of the populations of countries that are part of COVAX,” chief scientist Soumya Swaminathan told a Geneva news conference. These many doses will be enough “bring to an end the acute phase of the pandemic” by reducing mortality and the impact on health systems, she said. “Our goal, our hope is that in the first quarter of 2021 that we would have about half a billion of doses available to be distributed across the countries, in a fair manner,” Swaminathan said.
“So countries can start expecting doses toward the end of the first quarter of 2021. A few countries may start earlier, it’s likely, possible, that we may have some learnings by going early into a few countries,” she said without elaborating.
“But then the majority, the bulk of the tranches would probably start moving out in the second quarter of 2021.” COVAX is co-led by the GAVI vaccines alliance, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI).
COVID-19 vaccine will be a game changer: WHO
'Homegrown corona vaccine has no side-effect' claims female doctor taking first dose of Covaxin
